Investigating the mechanistic pathways of augmented volatile organic compounds related to the oesophagogastric cancer microbiome
Investigating the mechanistic pathways of augmented volatile organic compounds related to the oesophagogastric cancer microbiome
批准号:
75787
负责人:
金额:
$3.06万
依托单位:
依托单位国家:
英国
项目类别:
Study
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oesophagogastric cancer (cancer of the food pipe and stomach) is the fifth most common cancer in England and Wales with 16,000 new cases diagnosed every year. Currently only 15 out of every 100 patients diagnosed with this type of cancer live beyond 5 years. When oesophagogastric cancer is detected it is often in an advanced late stage. This is because symptoms associated with early disease are typically vague and common to a number of benign (non-cancer). It is not possible for GPs to send all patients who present with such symptoms for endoscopy, a 'camera test' to confirm the diagnosis of cancer, as this test is expensive and uncomfortable for patients. It is therefore important to develop new acceptable, accurate and affordable tests to help detect oesophagogastric cancer at an early stage.To address this problem, we are developing a non-invasive breath test for oesophagogastric cancer. The test is based on the detection of small molecules in exhaled breath called volatile organic compounds (VOCs). Our research has suggested that bacteria within the stomach of patients with oesophagogastric cancer are at least partly responsible for increased production of VOCs.This study intends to investigate the role of stomach bacteria in VOC production in oesophagogastric cancer. We will grow bacteria collected from cancer patients and measure their production of VOCs using mass spectrometry. We will conduct further experiments exploring what factors affect the production of VOCs from bacteria including the effects of growing bacteria and cancer cells together. Studying VOC production in this way will help us to understand how they are produced.This research is important because it can explain the underlying science behind a potentially innovative, non-invasive and cost-effective breath test to detect patients at risk of oesophagogastric cancer. Early diagnosis and treatment will lead to improved survival rates with global economic and societal benefits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
-
批准号:82371631
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:卢慕峻
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
TRIM25-PHGDH信号轴调控脓毒症肺上皮细胞铁死亡的机制研究
-
批准号:82372151
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:童尧
-
依托单位:
芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
-
批准号:82371809
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:聂红
-
依托单位:
脂滴聚集型小胶质细胞介导的髓鞘病变促进小鼠抑郁样行为及其机制研究
-
批准号:82371528
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李媛
-
依托单位:
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
-
批准号:82370920
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:周名亮
-
依托单位:
星形胶质细胞介导的髓鞘吞噬参与慢性脑低灌注白质损伤的机制研究
-
批准号:82371307
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:汤耀辉
-
依托单位: